Pyxis Oncology, Inc. (PYXS) Financials
PYXS Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 186.7 million | 48.7 million |
2023-06-30 | 175.2 million | 30.0 million |
2023-03-31 | 182.8 million | 30.6 million |
2022-12-31 | 211.4 million | 50.6 million |
PYXS Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -17.6 million | 5.2 million |
2023-06-30 | -13.3 million | 3.7 million |
2023-03-31 | -31.2 million | 4.9 million |
2022-12-31 | -19.2 million | 3.9 million |
PYXS Net Income
No data available :(
PYXS Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 133.0 million | - | 21.6 million |
2023-06-30 | 142.7 million | - | 21.3 million |
2023-03-31 | 149.3 million | - | 20.3 million |
2022-12-31 | 179.3 million | - | 18.9 million |
PYXS Shares Outstanding
PYXS Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | 61000 | 14.7 million | 10.7 million | - |
2023-06-30 | 2.3 million | 11.4 million | 6.7 million | - |
2023-03-31 | 4.4 million | 11.9 million | 9.1 million | - |
2022-12-31 | 1.9 million | 29.9 million | 8.1 million | - |
PYXS Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | - | 677000 |
2023-06-30 | - | 699000 |
2023-03-31 | - | 334000 |
2022-12-31 | - | 464000 |
PYXS
Price: $4.31
52 week price:
Earnings Per Share: -1.85 USD
P/E Ratio: -2.10
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 10300
Market Capitalization: 272.6 million